TrialArteriosclerosis, thrombosis, and vascular biology2021

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report.

Laurens F Reeskamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.